| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-07 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-06 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
1e-05 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-05 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |